TP53 and B-cell chronic lymphocytic leukemia: The status of tumor suppressor p53 (TP53 gene), with its main role as a promoter of cell cycle arrest and apoptosis, is still in use as a prognostic marker for the appropriate course of therapy for CLL patients.